Form 4 for JANX Janux Therapeutics, Inc.
Accepted 2024-09-27 00:00:00 ET · period of report 2024-09-27 · accession 0001415889-24-024078 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-09-27 | 2024-09-27 | JANX | Meyer Andrew Hollman | Chief Business Off | S - Sale+OE | $45.96 | -50.0K | 67.6K | -43% | -$2.30M |
| D | 2024-09-27 | 2024-09-27 | JANX | Meyer Andrew Hollman | Chief Business Off | M - OptEx | $4.21 | +50.0K | 117.6K | +74% | +$210.5K |
| D | 2024-09-27 | 2024-09-27 | JANX | Meyer Andrew Hollman | Chief Business Off | M - OptEx | $0.00 | -50.0K | 100.7K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-09-27 | S | D | 50,000 | $45.96 | 67,592 | D | — | — | (F2) The weighted average sale price for the transaction reported was $45.9551 and the range of prices were between $45.55 and $46.50. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. |
| 2 | Common | Common Stock | 2024-09-27 | M | A | 50,000 | $4.21 | 117,592 | D | — | — | (F1) Includes 1,189 shares acquired under the Issuer's 2021 Employee Stock Purchase Plan (the "Plan") on November 15, 2021, 1,752 shares acquired under the Plan on May 13, 2022, 2,401 shares acquired under the Plan on May 15, 2023 and 2,834 shares acquired under the Plan on May 15, 2024. |
| 3 | Derivative | Stock Option (right to buy) | 2024-09-27 | M | D | 50,000 | $0.00 | 100,667 | D | $4.21 · — to 2031-03-09 | 50,000 Common Stock | (F3) Immediately exercisable. |